Incidental Leydig Cell Tumor in Patient with Hormone Resistant Prostate Cancer

We hereby present the case of a 55 years old patient with clinical diagnosis of high-risk prostate cancer T2bN1Mo Gleason 9 (4 + 5) treated with androgen deprivation therapy and external beam radiotherapy. Despite treatment, castration levels were not achieved and clinical progression was evidenced...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez Pérez, M., Jiménez Marrero, P., Kim Lee, D., Neumann, M.P., Jorge Pérez, N., Hernández Hernández, C., Hernández Escobar, S., Marrero Domínguez, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397599/
https://www.ncbi.nlm.nih.gov/pubmed/28443242
http://dx.doi.org/10.1016/j.eucr.2017.03.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397599/
https://www.ncbi.nlm.nih.gov/pubmed/28443242
http://dx.doi.org/10.1016/j.eucr.2017.03.027

Ejemplares similares